HONOLULU — In patients with Barrett's esophagus, low-grade dysplasia carries a substantial risk for progression to esophageal adenocarcinoma, investigators report. The risk for progression in patients ...

“A diagnosis of low-grade dysplasia in Barrett’s esophagus warrants expert pathology review, as these patients may have a significant risk of developing esophageal cancer. However, expert pathology ...

By integrating data across multiple studies, this analysis confirms that TissueCypher provides consistent, reproducible ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a patient ...

A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC). Infusional ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified bile duct dysplasia or cholangiocarcinoma in 71% of explanted livers in the indication of ...

Please provide your email address to receive an email when new articles are posted on . After dysplasia resection in patients with inflammatory bowel disease, risk for colorectal cancer was low, ...

Credit: Getty Images A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis. A 29-year-old White man presents in May 2023 ...

Do bisphosphonates increase esophageal cancer risk? A meta-analysis. Background: Endoscopic submucosal dissection (ESD) is used for the treatment of gastric adenoma as well as early gastric cancer.

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication ...